PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
152.65M
RAFA
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
4.26M
Interact to see
Advertisement

PHCUF vs RAFA

Header iconPHCUF vs RAFA Comparison
Open Charts PHCUF vs RAFABanner chart's image
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization152.65M
Rafarma Pharmaceuticals, Inc. (WY)
Price$0.05
Change-$0.00 (-0.00%)
Volume$20.66K
Capitalization4.26M
PHCUF vs RAFA Comparison Chart in %
Loading...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHCUF vs. RAFA commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHCUF is a Hold and RAFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (PHCUF: $5.87 vs. RAFA: $0.05)
Brand notoriety: PHCUF and RAFA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PHCUF: 127% vs. RAFA: 55%
Market capitalization -- PHCUF: $152.65M vs. RAFA: $4.26M
PHCUF [@Pharmaceuticals: Generic] is valued at $152.65M. RAFA’s [@Pharmaceuticals: Generic] market capitalization is $4.26M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHCUF’s FA Score shows that 1 FA rating(s) are green whileRAFA’s FA Score has 2 green FA rating(s).

  • PHCUF’s FA Score: 1 green, 4 red.
  • RAFA’s FA Score: 2 green, 3 red.
According to our system of comparison, RAFA is a better buy in the long-term than PHCUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHCUF’s TA Score shows that 1 TA indicator(s) are bullish while RAFA’s TA Score has 3 bullish TA indicator(s).

  • PHCUF’s TA Score: 1 bullish, 3 bearish.
  • RAFA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PHCUF is a better buy in the short-term than RAFA.

Price Growth

PHCUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while RAFA (@Pharmaceuticals: Generic) price change was -19.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.18%. For the same industry, the average monthly price growth was +24.24%, and the average quarterly price growth was +67.33%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.18% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHCUF($153M) has a higher market cap than RAFA($4.26M). PHCUF YTD gains are higher at: 4.907 vs. RAFA (-37.217).
PHCUFRAFAPHCUF / RAFA
Capitalization153M4.26M3,594%
EBITDA44.5MN/A-
Gain YTD4.907-37.217-13%
P/E Ratio772.72N/A-
Revenue523MN/A-
Total Cash239MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
PHCUF vs RAFA: Fundamental Ratings
PHCUF
RAFA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
923
PRICE GROWTH RATING
1..100
4565
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RAFA's Valuation (71) in the null industry is in the same range as PHCUF (98). This means that RAFA’s stock grew similarly to PHCUF’s over the last 12 months.

RAFA's Profit vs Risk Rating (100) in the null industry is in the same range as PHCUF (100). This means that RAFA’s stock grew similarly to PHCUF’s over the last 12 months.

RAFA's SMR Rating (3) in the null industry is significantly better than the same rating for PHCUF (92). This means that RAFA’s stock grew significantly faster than PHCUF’s over the last 12 months.

PHCUF's Price Growth Rating (45) in the null industry is in the same range as RAFA (65). This means that PHCUF’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's P/E Growth Rating (2) in the null industry is in the same range as PHCUF (7). This means that RAFA’s stock grew similarly to PHCUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHCUFRAFA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 6 days ago
25%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
28%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
32%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
20%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALBKY0.960.05
+5.49%
Alpha Services and Holdings SA
SUWZX38.500.21
+0.55%
DWS Core Equity R6
MWTCF0.70N/A
N/A
Manila Water Co., Inc.
TAPP0.70N/A
N/A
Tap Resources, Inc.
RENEF12.11N/A
N/A
Cartesian Growth Corporation II

PHCUF and

Correlation & Price change

A.I.dvisor tells us that PHCUF and HTSUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHCUF and HTSUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HTSUF - PHCUF
26%
Poorly correlated
N/A
PCLOF - PHCUF
7%
Poorly correlated
-42.30%
RAFA - PHCUF
3%
Poorly correlated
+2.06%
OMID - PHCUF
3%
Poorly correlated
+2.15%
SFOSF - PHCUF
2%
Poorly correlated
N/A
More

RAFA and

Correlation & Price change

A.I.dvisor tells us that RAFA and SFOSF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFA and SFOSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFA
1D Price
Change %
RAFA100%
+2.06%
SFOSF - RAFA
9%
Poorly correlated
N/A
OWPC - RAFA
7%
Poorly correlated
+10.04%
RSCI - RAFA
7%
Poorly correlated
N/A
SBFM - RAFA
6%
Poorly correlated
-3.95%
TCNNF - RAFA
5%
Poorly correlated
+1.09%
More